MASTL Human Pre-designed siRNA Set A contains three designed siRNAs for MASTL gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAT2A Human Pre-designed siRNA Set A contains three designed siRNAs for MAT2A gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAT2A-IN-15 (compound 8) is an inhibitor of MAT2A[1].

MAT2B Human Pre-designed siRNA Set A contains three designed siRNAs for MAT2B gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MATE-IN-1 (Compound 31) is an inhibitor of MATE,with EC50 value of 1.8 μM. MATE-IN-1 has antibacterial activity[1].

MATK Human Pre-designed siRNA Set A contains three designed siRNAs for MATK gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MATN1 Human Pre-designed siRNA Set A contains three designed siRNAs for MATN1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MATN2 Human Pre-designed siRNA Set A contains three designed siRNAs for MATN2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MATN3 Human Pre-designed siRNA Set A contains three designed siRNAs for MATN3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MATN4 Human Pre-designed siRNA Set A contains three designed siRNAs for MATN4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MATR3 Human Pre-designed siRNA Set A contains three designed siRNAs for MATR3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAU2 Human Pre-designed siRNA Set A contains three designed siRNAs for MAU2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAVS Human Pre-designed siRNA Set A contains three designed siRNAs for MAVS gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAX Human Pre-designed siRNA Set A contains three designed siRNAs for MAX gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MAZ Human Pre-designed siRNA Set A contains three designed siRNAs for MAZ gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MB-07811 (VK-2809) is an orally active HepDirect prodrug of MB07344, a liver-targeted thyroid hormone receptor-β agonist[1]. MB-07811 has cholesterol and triglycerides lowering activity[2].

MB-07811 (VK-2809) is an orally active HepDirect prodrug of MB07344, a liver-targeted thyroid hormone receptor-β agonist[1]. MB-07811 has cholesterol and triglycerides lowering activity[2].

MB-07811 (VK-2809) is an orally active HepDirect prodrug of MB07344, a liver-targeted thyroid hormone receptor-β agonist[1]. MB-07811 has cholesterol and triglycerides lowering activity[2].

MB-07811 (VK-2809) is an orally active HepDirect prodrug of MB07344, a liver-targeted thyroid hormone receptor-β agonist[1]. MB-07811 has cholesterol and triglycerides lowering activity[2].

MB21D2 Human Pre-designed siRNA Set A contains three designed siRNAs for MB21D2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBD1 Human Pre-designed siRNA Set A contains three designed siRNAs for MBD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBD2 Human Pre-designed siRNA Set A contains three designed siRNAs for MBD2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBD3 Human Pre-designed siRNA Set A contains three designed siRNAs for MBD3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBD4 Human Pre-designed siRNA Set A contains three designed siRNAs for MBD4 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBD5 Human Pre-designed siRNA Set A contains three designed siRNAs for MBD5 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBD6 Human Pre-designed siRNA Set A contains three designed siRNAs for MBD6 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBIP Human Pre-designed siRNA Set A contains three designed siRNAs for MBIP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBL2 Human Pre-designed siRNA Set A contains three designed siRNAs for MBL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBLAC2 Human Pre-designed siRNA Set A contains three designed siRNAs for MBLAC2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBNL1 Human Pre-designed siRNA Set A contains three designed siRNAs for MBNL1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBNL2 Human Pre-designed siRNA Set A contains three designed siRNAs for MBNL2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBNL3 Human Pre-designed siRNA Set A contains three designed siRNAs for MBNL3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBOAT1 Human Pre-designed siRNA Set A contains three designed siRNAs for MBOAT1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBOAT7 Human Pre-designed siRNA Set A contains three designed siRNAs for MBOAT7 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBP Human Pre-designed siRNA Set A contains three designed siRNAs for MBP gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBTD1 Human Pre-designed siRNA Set A contains three designed siRNAs for MBTD1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBTPS1 Human Pre-designed siRNA Set A contains three designed siRNAs for MBTPS1 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBTPS2 Human Pre-designed siRNA Set A contains three designed siRNAs for MBTPS2 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

MBX3135 is an efflux pump inhibitor which can enhance the effect of antibiotics through the AcrB target of bacteria. MBX3135 can be used for research of infection and antibiotics[1].

MC-(β-Ala)-PABC-(β-D-GlcUA)-amide-PEG1-CH2-CC-885 (Comp Ie) is a neodegrader conjugate, can be used in the synthesis of antibody neoDegrader conjugate (AnDC)[1].

MC-(β-Ala)-PABC-(β-D-GlcUA)-amide-PEG1-CH2-CC-885 (Comp Ie) is a neodegrader conjugate, can be used in the synthesis of antibody neoDegrader conjugate (AnDC)[1].

MC-Gly-Gly-Phe-Gly-GABA-Exatecan is an agent linker conjugate for ADC, with an inhibitor for Topoisomerase Exatecan (HY-13631) with IC50 of 22 μM. MC-Gly-Gly-Phe-Gly-GABA-Exatecan targets various antibodies, exhibits cytotoxic and antitumor efficacy in vitro and in vivo[1][2].